期刊
NEUROREPORT
卷 22, 期 13, 页码 637-641出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WNR.0b013e328349739b
关键词
[H-3]-CGP54626A; clozapine; GABA(B) receptor N-desmethylclozapine; schizophrenia
资金
- SickKids Foundation
- CIHR
- National Alliance for Research on Schizophrenia and Depression
Neurophysiological studies suggest that clozapine may facilitate gamma-aminobutyric acid (GABAergic) neurotransmission. Therefore, we studied the interaction between clozapine and the GABA(B) receptor (GABA(B)R). We showed that clozapine, and not N-desmethylclozapine, which is a metabolite of clozapine, increased the binding of the GABA(B)R antagonist, [H-3]-CGP54626A, at GABA(B)Rs. Linear regression analysis showed that the correlation between the dose of clozapine and the increase of [H-3]-CGP54626A binding was significant. The curve of specific [H-3]-CGP54626A binding in competition with different concentrations of GABA was left shifted in the presence of clozapine. With HEK293 cells overexpressing GABA(B)R, we showed that clozapine had a significant increase of [H-3]-CGP54626A binding at GABA(B)R1 subunit, which provided a clue of the potential therapeutic target of clozapine. NeuroReport 22:637-641 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据